| Emily Grace Atharinikrouh, FNP | |
|
400 Hickory St Nw Ste 303, Albany, OR 97321-1700 | |
| (541) 812-5275 | |
| Not Available |
| Full Name | Emily Grace Atharinikrouh |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 400 Hickory St Nw Ste 303, Albany, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639424104 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP2300X | Nurse Practitioner - Primary Care | 201250097NP (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Samaritan Albany General Hospital | Albany, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany General Hospital | 9931097987 | 162 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Two de-identification methods, k-anonymization and adding a "fuzzy factor," significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
A traumatic brain injury happens in an instant: a battlefield blast, a car crash, a bad fall. But the effects can last a lifetime - and can leave the survivor dependent on daily care from their loved ones for decades.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.
› Verified 9 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20031111000297 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Two de-identification methods, k-anonymization and adding a "fuzzy factor," significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
A traumatic brain injury happens in an instant: a battlefield blast, a car crash, a bad fall. But the effects can last a lifetime - and can leave the survivor dependent on daily care from their loved ones for decades.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.
› Verified 9 days ago
| Entity Name | Good Samaritan Hospital Corvallis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962453134 PECOS PAC ID: 1557270725 Enrollment ID: O20031125000163 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Two de-identification methods, k-anonymization and adding a "fuzzy factor," significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
A traumatic brain injury happens in an instant: a battlefield blast, a car crash, a bad fall. But the effects can last a lifetime - and can leave the survivor dependent on daily care from their loved ones for decades.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.
› Verified 9 days ago
| Entity Name | Willamette Valley Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790740520 PECOS PAC ID: 6103729314 Enrollment ID: O20040127000785 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Two de-identification methods, k-anonymization and adding a "fuzzy factor," significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
A traumatic brain injury happens in an instant: a battlefield blast, a car crash, a bad fall. But the effects can last a lifetime - and can leave the survivor dependent on daily care from their loved ones for decades.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.
› Verified 9 days ago
| Entity Name | Albany General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372340 PECOS PAC ID: 9931097987 Enrollment ID: O20040310000310 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Two de-identification methods, k-anonymization and adding a "fuzzy factor," significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
A traumatic brain injury happens in an instant: a battlefield blast, a car crash, a bad fall. But the effects can last a lifetime - and can leave the survivor dependent on daily care from their loved ones for decades.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.
› Verified 9 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20061104000140 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Two de-identification methods, k-anonymization and adding a "fuzzy factor," significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
A traumatic brain injury happens in an instant: a battlefield blast, a car crash, a bad fall. But the effects can last a lifetime - and can leave the survivor dependent on daily care from their loved ones for decades.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.
› Verified 9 days ago
| Entity Name | Urgent Care Oregon Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790706190 PECOS PAC ID: 2668563750 Enrollment ID: O20070803000109 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Two de-identification methods, k-anonymization and adding a "fuzzy factor," significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
A traumatic brain injury happens in an instant: a battlefield blast, a car crash, a bad fall. But the effects can last a lifetime - and can leave the survivor dependent on daily care from their loved ones for decades.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.
› Verified 9 days ago
| Entity Name | Emurgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265871123 PECOS PAC ID: 9830325075 Enrollment ID: O20131119000265 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Two de-identification methods, k-anonymization and adding a "fuzzy factor," significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
A traumatic brain injury happens in an instant: a battlefield blast, a car crash, a bad fall. But the effects can last a lifetime - and can leave the survivor dependent on daily care from their loved ones for decades.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Grace Atharinikrouh, FNP Po Box 1189, Corvallis, OR 97339-1189 Ph: () - | Emily Grace Atharinikrouh, FNP 400 Hickory St Nw Ste 303, Albany, OR 97321-1700 Ph: (541) 812-5275 |
News Archive
Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Two de-identification methods, k-anonymization and adding a "fuzzy factor," significantly reduced the risk of re-identification of patients in a dataset of 5 million patient records from a large cervical cancer screening program in Norway.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
A traumatic brain injury happens in an instant: a battlefield blast, a car crash, a bad fall. But the effects can last a lifetime - and can leave the survivor dependent on daily care from their loved ones for decades.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.
› Verified 9 days ago
Huei Ling Tsai, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2832 Weather Stone St Nw # Na, Albany, OR 97321 Phone: 415-619-4332 | |
Ms. Virginia J Taylor, CFNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1100 7th Ave Sw, Albany, OR 97321 Phone: 541-812-4980 Fax: 541-926-9329 | |
Mrs. Jessica Anne Henry, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1700 Geary St Se, Albany, OR 97322 Phone: 541-812-5500 | |
Ms. Jennifer Marie Wilson, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1700 Geary St Se, Albany, OR 97322 Phone: 541-812-5500 | |
Susan Parker, RN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1005 Springhill Dr. Nw, Albany, OR 97321 Phone: 541-967-4518 | |
Mrs. Yvonne Elaine Keep, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1705 Waverly Dr Se, Albany, OR 97322 Phone: 541-967-8221 | |
Jonell Blase, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1100 7th Ave Sw, Albany, OR 97321 Phone: 541-812-5600 |